Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

151
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
151
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

115
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
115
Clinical Trials01:16

Clinical Trials

6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

313
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
313
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

814
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
814

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RankVar: machine learning-based variant ranking and reinterpretation for rare genetic diseases.

Genome medicine·2026
Same author

Improving Retrieval-Augmented Generation without Taxonomy-based Error Categorization.

Proceedings of the conference. Association for Computational Linguistics. Meeting·2026
Same author

Evaluating unsupervised and rule-based phenotyping methods versus administrative code counts for systemic sclerosis identification.

Seminars in arthritis and rheumatism·2026
Same author

Hard to Halt: Automation Bias in Agent-Driven Sequencing Prior Authorization Workflows.

medRxiv : the preprint server for health sciences·2026
Same author

Unsupervised characterization of 100,272 EHR patients identifies high-risk groups and comorbidities linked to premature aging.

NPJ digital medicine·2026
Same author

TimeX: Phenotype Onset Extraction from Clinical Narratives.

npj health systems·2026

Related Experiment Video

Updated: Jul 31, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K

A data-driven approach to optimizing clinical study eligibility criteria.

Yilu Fang1, Hao Liu1, Betina Idnay1

  • 1Department of Biomedical Informatics, Columbia University, New York, NY, USA.

Journal of Biomedical Informatics
|May 4, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces OPTEC (OPTimal Eligibility Criteria), a novel model for optimizing clinical trial eligibility criteria. OPTEC ensures feasible, safe, and inclusive criteria, improving patient recruitment and cohort diversity.

Keywords:
Clinical studyElectronic health recordsOptimizationParticipant selection

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K

Related Experiment Videos

Last Updated: Jul 31, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K

Area of Science:

  • Clinical research methodology
  • Health informatics
  • Decision science

Background:

  • Effective clinical research relies on feasible, safe, and inclusive eligibility criteria for successful patient recruitment.
  • Current expert-centered methods may not accurately reflect real-world patient populations.
  • Optimizing eligibility criteria is essential for generating representative and generalizable research findings.

Purpose of the Study:

  • To present a novel model, OPTEC (OPTimal Eligibility Criteria), for systematically identifying optimal eligibility criteria combinations.
  • To achieve an optimal balance between feasibility, patient safety, and cohort diversity in clinical research.
  • To offer a flexible and generalizable approach applicable to various clinical domains.

Main Methods:

  • Development of the OPTEC model utilizing Multiple Attribute Decision Making (MADM) enhanced by a greedy algorithm.
  • Systematic identification of optimal criteria combinations based on user-specified prioritization.
  • Evaluation of the model on Alzheimer's disease and pancreatic cancer using MIMIC-III and NYP/CUIMC databases.

Main Results:

  • OPTEC successfully simulated the optimization of eligibility criteria, generating recommendations from the top-ranked combinations (0.41-2.75%).
  • An interactive criteria recommendation system was developed based on the OPTEC model.
  • A case study with a clinical researcher using a think-aloud protocol validated the system's utility.

Conclusions:

  • The OPTEC model effectively recommends feasible eligibility criteria combinations.
  • The system provides actionable insights for clinical study designers to establish feasible, safe, and diverse cohorts.
  • This approach supports the early stages of clinical study design for improved recruitment and representativeness.